Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$27.7 - $31.39 $277,000 - $313,900
10,000 New
10,000 $289,000
Q4 2023

Jan 24, 2024

BUY
$26.13 - $33.94 $653,250 - $848,500
25,000 New
25,000 $719,000
Q2 2023

Jul 26, 2023

SELL
$36.12 - $41.79 $361,200 - $417,900
-10,000 Reduced 25.0%
30,000 $1.1 Million
Q1 2023

May 02, 2023

BUY
$39.39 - $51.28 $1.58 Million - $2.05 Million
40,000 New
40,000 $1.63 Million
Q3 2022

Oct 21, 2022

BUY
$43.76 - $53.42 $1.31 Million - $1.6 Million
30,000 New
30,000 $1.31 Million
Q1 2022

May 02, 2022

SELL
$45.75 - $56.69 $228,750 - $283,450
-5,000 Reduced 20.0%
20,000 $1.04 Million
Q4 2021

Feb 03, 2022

BUY
$41.32 - $61.25 $1.03 Million - $1.53 Million
25,000 New
25,000 $1.48 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Arkadios Wealth Advisors Portfolio

Follow Arkadios Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Arkadios Wealth Advisors with notifications on news.